» Articles » PMID: 34012282

Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence

Overview
Publisher Dove Medical Press
Specialty Dermatology
Date 2021 May 20
PMID 34012282
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Alopecia is a clinical condition related to hair loss that can significantly affect both male and female adults' quality of life. Despite the high market demand, only few drugs are currently approved for alopecia treatment. Topical formulations still bring drawbacks, such as scalp irritation with frequent use, and low drug absorption to the site of action, which limits the efficacy. The most recent research points out that different formulation technology could circumvent the aforementioned flaws. Such technology includes incorporation of drugs in rigid or deformable nanoparticles, strategies involving physical, energetical and mechanical techniques, such as iontophoresis, sonophoresis, microneedling, and the use of solid effervescent granules to be hydrated at the moment of application in the scalp. In this paper, the progress of current research on topical formulations dedicated to the treatment of alopecia is reviewed and discussed.

Citing Articles

The Acid-Buffered Engineered Gel Promotes In Vitro Cutaneous Healing and Fights Resistant Bacteria in Wounds.

Abid F, Virgo E, Kennewell T, Khetan R, Haidari H, Kopecki Z Pharmaceutics. 2024; 16(11).

PMID: 39598606 PMC: 11597482. DOI: 10.3390/pharmaceutics16111484.


The role of salivary vitamin D and interleukin-6 on non-scarring Alopecia.

Zufishan S, Lateef T Arch Dermatol Res. 2024; 316(10):695.

PMID: 39412537 DOI: 10.1007/s00403-024-03416-z.


Synergistic Phytochemical and Pharmacological Actions of Hair Rise Microemulsion: A Novel Herbal Formulation for Androgenetic Alopecia and Hair Growth Stimulation.

Muangsanguan A, Ruksiriwanich W, Linsaenkart P, Jantrawut P, Rachtanapun P, Jantanasakulwong K Plants (Basel). 2024; 13(19).

PMID: 39409672 PMC: 11479085. DOI: 10.3390/plants13192802.


Enhancing hair regeneration: Recent progress in tailoring nanostructured lipid carriers through surface modification strategies.

Atrooz O, Reihani N, Mozafari M, Salawi A, Taghavi E ADMET DMPK. 2024; 12(3):431-462.

PMID: 39091900 PMC: 11289513. DOI: 10.5599/admet.2376.


Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy.

Jin S, Sung J Int J Mol Sci. 2024; 25(14).

PMID: 39062852 PMC: 11277092. DOI: 10.3390/ijms25147612.


References
1.
Zhai Y, Zhai G . Advances in lipid-based colloid systems as drug carrier for topic delivery. J Control Release. 2014; 193:90-9. DOI: 10.1016/j.jconrel.2014.05.054. View

2.
Gomes M, Martins S, Ferreira D, Segundo M, Reis S . Lipid nanoparticles for topical and transdermal application for alopecia treatment: development, physicochemical characterization, and in vitro release and penetration studies. Int J Nanomedicine. 2014; 9:1231-42. PMC: 3952901. DOI: 10.2147/IJN.S45561. View

3.
Oliveira A, Oliveira P, Cunha-Filho M, Gratieri T, Gelfuso G . Latanoprost Loaded in Polymeric Nanocapsules for Effective Topical Treatment of Alopecia. AAPS PharmSciTech. 2020; 21(8):305. DOI: 10.1208/s12249-020-01863-1. View

4.
Lee S, Lee W . Management of alopecia areata: Updates and algorithmic approach. J Dermatol. 2017; 44(11):1199-1211. DOI: 10.1111/1346-8138.13933. View

5.
Randolph M, Tosti A . Oral minoxidil treatment for hair loss: A review of efficacy and safety. J Am Acad Dermatol. 2020; 84(3):737-746. DOI: 10.1016/j.jaad.2020.06.1009. View